News

In this month's Innovation Column, Drs. Steve Xu and William Ju discuss the need for entrepreneurship education in medical school and residency training.

Identifying the presence of bacterial and fungal species improves antimicrobial therapy, according to a recent review published in the July issue of Advances in Wound Care.

Image IQ:  A 43-year-old man with a symmetrical palpable purpura rash on his legs. What’s your diagnosis?

Women in treatment for skin diseases, including psoriasis, experience higher levels of non-psychotic psychiatric disorders, including anxiety and depression, than men.

For women with psoriasis, psoriatic arthritis, and ankylosing spondylitis who take secukinumab during pregnancy or conception, recent research shows adverse pregnancy events don’t happen at a higher rate.

A 10-year-old girl is experiencing hair loss with no signs of lesions or scarring on her scalp. What’s your diagnosis?

Photodynamic therapy (PDT) has multiple uses, but billing can be complicated. In this article, we outline its uses and billing codes.

Gender and sex play a part in detemining which topical products are most successful for patients. This table is compiled based on a review of articles form the International Journal of Women's Dermatology.

Patients that schedule regular mammograms could easily be encouraged to screen for melanoma via self-skin examination when given instructions at their breast cancer screenings, according to a recent study. This type of intervention program could be an effective strategy to increase skin cancer awareness.

Patients in outpatient primary care clinics are choosing to learn about genomic testing to detemine their risk of melanoma, according to a recent clinical trial. 

Congress has proposed two bills that are designed to promote a "scientific exchange" between drug manufacturers and physcians. As a result, drug manufacturers may be able to share clinical data and non-FDA-approved uses of drugs with healthcare providers in the future.

A nodule develops over the course of months with pain, swelling, distal numbness and muscle weakness. What’s your diagnosis?

As more dermatologists implement EHR systems, many are wondering if EHR adoption will increase or decrease their medical legal liability. Dr. David Goldberg provides his insight in this month's legal column.

In this month's Innovation Column, Drs. Steve Xu and William Ju discuss the unique advantage dermatologists have when it comes to innovation in healthcare.

The FDA has approved Ortho Dermatologic’s new drug application for Altreno (tretinoin 0.05 percent) lotion for the treatment of acne vulgaris.

Developing doctor-patient relationships are key to avoiding oversimplification of characteristics like race and gender, which can result in stereotyping and medical mismanagement.

A literature review by an international group of physicians shows that the physiological skin parameters differ among men and women suggesting that treatment choices should differ as well.

Can clinicians working for Catholic health care organizations prescribe the birth control pill for acne? A recent article discusses the ethical and legal problems these clinicians face when patients request to be treated with oral contraceptives.

EADV report summarizes the latest advances in laser technology for tattoo removal.

EADV report shows that two JAK inhibitors reverses alopecia areata in some patients.

Pennsylvania Dermatology Partners tells its story of technological support and success.

Discordance between increase in billed procedures vs increase in number of patients.

Until the approval of Eskata (hydrogen peroxide) for the treatment of raised seborrheic keratosis back in December, there was no FDA-approved treatment for this condition. Learn the latest in this article.

Researchers writing in JAMA Dermatology report that patients diagnosed with hidradenitis suppurativa (HS) are at a higher risk for having or developing Crohn’s disease (CD).

The FDA is exploring ways to prevent long-term drug shortages and allow more drug importation so patients have access to medically necessary drugs.

Physicians throughout the country are recruiting patients for two phase three clinical trials of cantharidin for the treatment of molluscum contagiousum. a viral skin condition.

Ortho Dermatologics announced in August that it resubmitted a new drug application to the FDA for DUOBRIITM1, a lotion for the treatment of plaque psoriasis.

In October, the Food and Drug Administratin is expected to decide on the approval of omadacycline (Paratek Pharmaceuticals) for the treatment of acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia.